anti-LAG-3/anti-TIGIT mAb (Merck)

N/A

Report date: 2025/01/26 19:13:08

Base Information

Drug Nameanti-LAG-3/anti-TIGIT mAb (Merck)
Drug Alias Nameanti-LAG-3 mAb (Merck & Co)28G10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionT cell immunoglobulin and ITIM domains inhibitorsLymphocyte activation gene 3 protein modulators
TargetsLymphocyte activation gene 3 proteinT cell immunoglobulin and ITIM domains
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme LLC
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A